Articles from BIOTECH Patent News (August 1, 2002)

1-34 out of 34 article(s)

Title	Type	Words
AMT licenses rights on IL-10 for ex-vivo gene therapy.	Brief Article	410
ARCH obtains United States patent.	Brief Article	80
ARCH obtains United States patent.	Brief Article	75
ARCH obtains United States patent.	Brief Article	132
ARCH obtains United States patent.	Brief Article	146
ARCH obtains United States patent.	Brief Article	152
ARCH obtains United States patent.	Brief Article	78
ARCH obtains United States patent.	Brief Article	78
ARCH obtains United States patent.	Brief Article	52
ARCH obtains United States patent.	Brief Article	119
ARCH obtains United States patent.	Brief Article	113
ARCH obtains United States patent.	Brief Article	198
ARCH obtains United States patent.	Brief Article	67
ARCH obtains United States patent.	Brief Article	138
ARCH obtains United States patent.	Brief Article	39
Blood pump technology patent granted to MedQuest.	Brief Article	449
Cell Genesys issued patent for oncolytic virus.	Brief Article	595
Coley receives dendritic cell patent.	Brief Article	711
Debiopharm extends collaboration with Sanofi-Synthelabo.	Brief Article	479
Demegen awarded D-amino acid peptide European patents.	Brief Article	286
DNAPrint applies for patent covering 2,425 SNPs.		472
Evotec grants gene fragment patent licence to Roche Diagnostics.	Brief Article	433
GeneMax obtains immunotherapy patent.	Brief Article	487
Hybridon announces issuance of a patent covering CpG oligonucleotides.	Brief Article	302
Isis achieves milestone in Amgen antisense collaboration.	Brief Article	450
Lexicon patents gene trapping technology.	Brief Article	441
MedImmune licenses rights to human metapneumovirus.	Brief Article	875
Patent expands Diversa's gene evolution portfolio.	Brief Article	291
PRIMABioMed achieves clinical advancement and cancer and arthritis patent.	Brief Article	561
Research & Diagnostic Antibodies patents immunoassays that detect inducible nitric oxide synthase.	Brief Article	603
Ribapharm files patent infringement lawsuit against Hoffmann-La Roche.	Brief Article	338
Ribapharm sues Hoffmann-La Roche in Germany over ribavirin patent.	Brief Article	282
Sangart patents blood substitute.	Brief Article	521
Targeted Genetics' obtains adeno-associated virus patent.	Brief Article	693